New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 14, 2022, - Medicines360 announced the FDA approval of Liletta (levonorgestrel-releasing intrauterine system), for prevention of pregnancy for up to 8 years.
Download PDF
Return to publications
